Neurocrine Biosciences, Inc. (NBIX) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGS. Market cap 14.36B USD. 52-week range 122.14 to 186.12 USD. Trailing P/E 20.7. Data as of 2026-10-09.
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI ...